Additional cancer specific network modules (Figure 4 and Supplement) reflect TP53 point mutation linked to a number of TP53 targets in uterine cancer (Figure 4, vi), and enrichment of solute carrier encoding genes in kidney cancer (Figure 4, viii). The gene discussed is TP53; the disease is uterine cancer.